Veloxis Stock Performance

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>VEL</div>
The entity has a beta of 0.0, which indicates the returns on MARKET and Veloxis Pharmaceuticals are completely uncorrelated. Although it is extremely important to respect Veloxis Pharmaceuticals current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting Veloxis Pharmaceuticals technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Veloxis Pharmaceuticals right now has a risk of 0.0%. Please validate Veloxis Pharmaceuticals Jensen Alpha, Maximum Drawdown and the relationship between Information Ratio and Treynor Ratio to decide if Veloxis Pharmaceuticals will be following its existing price patterns.
View Stock Performance For

Veloxis Pharmaceuticals Risk-Adjusted Performance

Over the last 30 days Veloxis Pharmaceuticals AS has generated negative risk-adjusted returns adding no value to investors with long positions. Allthough quite persistent forward indicators, Veloxis Pharmaceuticals is not utilizing all of its potentials. The existing stock price mess, may contribute to short term losses for the partners.
Quick Ratio3.06
Fifty Two Week Low0.9600
Target High Price1.33
Fifty Two Week High3.5350
Target Low Price1.33

Veloxis Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest (100.00)  in Veloxis Pharmaceuticals AS on March 5, 2020 and sell it today you would earn a total of  100.00  from holding Veloxis Pharmaceuticals AS or generate -100.0% return on investment over 30 days. Veloxis Pharmaceuticals AS is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than Veloxis Pharmaceuticals and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
  Risk (%) 

Veloxis Pharmaceuticals Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average Veloxis Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Veloxis Pharmaceuticals by adding it to a well-diversified portfolio.

Veloxis Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Veloxis Pharmaceuticals is not yet fully synchronised with the market data
Veloxis Pharmaceuticals has some characteristics of a very speculative penny stock
Veloxis Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported revenue of 46.49 M. Net Loss for the year was (1.14 M) with profit before overhead, payroll, taxes, and interest of 31.58 M.
VELOXIS PHARMACEU has accumulated about 28.39 M in cash with (8.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check out World Market Map. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page